Human rhinovirus VP4 forms a size-selective multimeric pore in membranes, providing a molecular mechanism for viral genome delivery and a potential novel antiviral target.
No takes yet. Share an insight, caveat, or question.
VP4 pore formation suggests a novel rhinovirus antiviral target; leaves open translation from recombinant systems to in vivo efficacy.
Panjwani et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: